Singapore, Nov. 25 -- Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreement with Batterjee Pharma, a leading Saudi pharmaceutical company, becoming the first Lebanese company to localise its portfolio in the Kingdom.
The agreement covers the manufacturing and supply of several EU & Japanese licensed Algorithm products.
The collaboration will kick off with products targeting the treatment of critical therapeutic areas as hyperlipidemia, dyslipidemia & hypertension with full technology transfer by mid-2026.
Aligned with KSA's Health Sector Transformation Programme under Vision 2030, this partnership will strengthen the Kingdom's healthcare infrastructure, reduce relian...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.